Clinical Trial Update: Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability [NA]

View source ↗

Summary

Phase 2 trial evaluating ex-vivo lung perfusion and ventilation to assess transplant suitability, sponsored by the University of North Carolina, Chapel Hill; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Bronchiectasis
• Chronic Obstructive Pulmonary Disease
• Cystic Fibrosis
• Emphysema
• Pulmonary Fibrosis
• Pulmonary Hypertension
• Sarcoidosis

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Emphysema, Chronic Obstructive Pulmonary Disease (COPD) | NA | Status: TERMINATED